|
Immunotherapy
Citations 361-370 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo
- Shuiping Jiang, Niels Camara, Giovanna Lombardi, and Robert I. Lechler
Blood 2003; 102: 2180-2186.
[Abstract]
[Full text]
[PDF]
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses
- Persis J. Amrolia, Giada Muccioli-Casadei, Eric Yvon, Helen Huls, Uluhan Sili, Eric D. Wieder, Catherine Bollard, Jaroslav Michalek, Victor Ghetie, Helen E. Heslop, Jeffrey J. Molldrem, Cliona M. Rooney, John Schlinder, Ellen Vitetta, and Malcolm K. Brenner
Blood 2003; 102: 2292-2299.
[Abstract]
[Full text]
[PDF]
Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-
- Marie-Therese Rubio, Yong-Mi Kim, Teviah Sachs, Markus Mapara, Guiling Zhao, and Megan Sykes
Blood 2003; 102: 2300-2307.
[Abstract]
[Full text]
[PDF]
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation
- Martha Wadleigh, Paul G. Richardson, David Zahrieh, Stephanie J. Lee, Corey Cutler, Vincent Ho, Edwin P. Alyea, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer, and Daniel J. DeAngelo
Blood 2003; 102: 1578-1582.
[Abstract]
[Full text]
[PDF]
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
- Joseph H. Antin, Haesook T. Kim, Corey Cutler, Vincent T. Ho, Stephanie J. Lee, David B. Miklos, Ephraim P. Hochberg, Catherine J. Wu, Edwin P. Alyea, and Robert J. Soiffer
Blood 2003; 102: 1601-1605.
[Abstract]
[Full text]
[PDF]
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
- Oliver W. Press, Joseph M. Unger, Rita M. Braziel, David G. Maloney, Thomas P. Miller, Michael LeBlanc, Ellen R. Gaynor, Saul E. Rivkin, and Richard I. Fisher
Blood 2003; 102: 1606-1612.
[Abstract]
[Full text]
[PDF]
CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation
- Keith Crawford, Aleksandra Stark, Betsy Kitchens, Kerry Sternheim, Vassilios Pantazopoulos, Ellen Triantafellow, Zhigang Wang, Baldev Vasir, Charles E. Larsen, Dana Gabuzda, Ellis Reinherz, and Chester A. Alper
Blood 2003; 102: 1745-1752.
[Abstract]
[Full text]
[PDF]
Rapid recovery from T lymphopenia by CD28 superagonist therapy
- Karin Elflein, Marta Rodriguez-Palmero, Thomas Kerkau, and Thomas Hünig
Blood 2003; 102: 1764-1770.
[Abstract]
[Full text]
[PDF]
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor
- Justin Stebbing, Brian Gazzard, Simon Portsmouth, Frances Gotch, Louise Kim, Mark Bower, Sundhiya Mandalia, Robert Binder, Pramod Srivastava, and Steve Patterson
Blood 2003; 102: 1806-1814.
[Abstract]
[Full text]
[PDF]
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
- Ji-yan Liu, Yu-quan Wei, Li Yang, Xia Zhao, Ling Tian, Jian-mei Hou, Ting Niu, Fen Liu, Yu Jiang, Bing Hu, Yang Wu, Jing-mei Su, Yan-yan Lou, Qiu-ming He, Yan-jun Wen, Jin-liang Yang, Bing Kan, Yong-qiu Mao, Feng Luo, and Feng Peng
Blood 2003; 102: 1815-1823.
[Abstract]
[Full text]
[PDF]
|
|
